SCHEMBL24578796

SCHEMBL24578796

Cc1cnn2cc(-c3cnn(C(C)C#N)c3)sc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577874 0.75 FLT3 (0.38) —
SCHEMBL24578878 0.69 KDR (0.38) —
SCHEMBL24577085 0.68 KIT (0.39) —
SCHEMBL24577209 0.68 JAK2 (0.39) —
SCHEMBL24577715 0.68 CHRNB2 (0.32) —
SCHEMBL15033921 0.67 MAP4K1 (0.34) MAP4K1
SCHEMBL20056947 0.67 MAP4K1 (0.34) MAP4K1
SCHEMBL21850519 0.67 MAP4K1 (0.34) MAP4K1
SCHEMBL24579168 0.67 KIT (0.43) —
SCHEMBL24578525 0.66 BRAF (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback